Actively Recruiting
CHM for Female Stress Urinary Incontinence
Led by Hong Kong Baptist University · Updated on 2025-11-20
15
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This single-arm, open-label pilot clinical trial will test the hypothesis that S-2196, a Chinese herbal medicine formula, will show efficacy and safety in alleviating the amount and frequency of urinary incontinence in female individuals with stress urinary incontinence. All participants (n=15) will receive 1 week of screening, 2 weeks of intervention, and 1 week of follow-up.
CONDITIONS
Official Title
CHM for Female Stress Urinary Incontinence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 55 years or older
- Diagnosed with stress urinary incontinence according to ICUD criteria
- Urine leakage greater than 10 grams in the 1-hour standard pad test
- Able to understand and follow instructions in Chinese
- Able to independently use and complete the electronic diary during the 1-week screening
- Provided informed consent voluntarily
You will not qualify if you...
- Having other types of urinary incontinence such as neurogenic, urge, or overflow incontinence
- Presence of urogenital diseases like vesicoureteral reflux, detrusor instability, congenital urethral abnormalities, urinary tract infection, hematuria, urogenital fistula, urethral diverticulum, bladder stones, urinary system tumors, abnormal vaginal bleeding, pelvic malignant tumors, or grade II or higher uterine prolapse
- History of surgery for stress urinary incontinence or complex urethral surgery
- Previous pelvic radiotherapy, radical surgery for pelvic tumors, or pelvic floor surgery
- Currently undergoing or needing ongoing treatment for urinary incontinence including pelvic floor muscle training, physical therapy, pessary, or medication
- Use of medications affecting urination during screening or unstable dose during study
- Presence of neurological disorders, diabetes, connective tissue diseases, mental disorders, hypertension, severe cardiovascular or cerebrovascular diseases, severe liver or kidney diseases
- Chronic cough diseases like COPD, gastrointestinal diseases affecting drug absorption, or other unstable chronic diseases
- History of adverse reactions to traditional Chinese medicine or G6PD deficiency
- Unable to perform walking or stair climbing exercises
- Deemed unsuitable by researchers due to psychological or physical reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hong Kong Baptist University
Hong Kong, Hong Kong
Actively Recruiting
Research Team
Z
ZhaoXiang Bian, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here